Volume 11, Number 9—September 2005
Research
Molecular Epidemiology of SARS-associated Coronavirus, Beijing
Table 1
Position | Amplification region* | Primer sets (starting from 5´) | |
---|---|---|---|
17564 | 17440–18281 | Forward | ACGTCTATATTGGCGATCCT TGTGCAGACTTATGAAAACAATA |
Reverse | GTTTTGCATTAACTCTGGTG GTTAGTACCCACAGCATCTCTAGT | ||
21721 | 21585–22304 | Forward | GATGATGTTCAAGCTCCTAATTAC CTTAACAGAGCATTTGAGTTCAG |
Reverse | CAACATACTTCATCTATGAGGGG TGTACCATTTTCATCATACTTGAG | ||
22222 | 22177–22874 | Forward | AGATGTAGTTCGTGATCTACCTTC TTAATGGCCAATAACAATTAAGA |
Reverse | CAAATTTTAGAGCCATTCTTACAG GGAGAAAGGCACATTAGATATGTC | ||
23823 | 23455–24263 | Forward | CGACACTTCTTATGAGTGCG ATGCAGTTGATGTTGTTGTAAG |
Reverse | GCATTTGTGCTAGTTACCATACAG TGATGTTGTTGTAAGTGATTCTTG | ||
27827 | 27449–28270 | Forward | CCATCAGGAACATACGAGG GACCACTATTGGTGTTGATTG |
Reverse | TAGCACACACTTTGCTTTTG CAGTATTATTGGGTAAACCTTGG |
*The nucleotide position was given with TOR2 as the reference strain (accession no. NC004718).
Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.